CD320 and Miyoshi myopathy: Although CD320 is known to be associated with B-cell survival and proliferation [82,83], and FAM3C is a known inducer of osteoblast differentiation [84,85], their effect on the tumor microenvironment and their role in MM progression is subject to further research.